Rockwell Medical (RMTI) Receiving Somewhat Favorable News Coverage, Study Finds

News stories about Rockwell Medical (NASDAQ:RMTI) have trended somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Rockwell Medical earned a news impact score of 0.06 on Accern’s scale. Accern also gave news articles about the company an impact score of 45.7091301707382 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

RMTI has been the subject of several research reports. Zacks Investment Research downgraded shares of Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Thursday, January 4th. BidaskClub downgraded shares of Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Thursday.

Rockwell Medical (NASDAQ:RMTI) traded down $0.06 during midday trading on Thursday, reaching $5.81. 220,406 shares of the company traded hands, compared to its average volume of 327,055. Rockwell Medical has a twelve month low of $5.06 and a twelve month high of $8.98. The firm has a market cap of $303.84, a P/E ratio of -13.50 and a beta of 2.02.

Rockwell Medical (NASDAQ:RMTI) last posted its quarterly earnings results on Wednesday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.10). Rockwell Medical had a negative net margin of 39.28% and a negative return on equity of 46.63%. The business had revenue of $14.63 million during the quarter, compared to the consensus estimate of $13.33 million. During the same quarter last year, the firm posted ($0.09) EPS. Rockwell Medical’s revenue was up 14.2% compared to the same quarter last year. analysts forecast that Rockwell Medical will post -0.44 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3144182/rockwell-medical-rmti-receiving-somewhat-favorable-news-coverage-study-finds.html.

About Rockwell Medical

Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.

Insider Buying and Selling by Quarter for Rockwell Medical (NASDAQ:RMTI)

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.